Joint Venture – Life Sciences

Our client, an experienced research scientist and educator, approached MillCrest Law to assist her with the negotiation and documentation of a joint venture arrangement with a publicly traded biotech company focused on the development of novel immune-based cancer therapies. Each party contributed intellectual property to the joint venture, either by license or outright assignment, to be used in the discovery of new molecular targets and the development of monoclonal antibodies. Our client serves as the CEO of the joint venture entity and overseas all of its research and development activities.

At MillCrest Law, our focus is to grow our business with yours.

Comments are closed.